Event

Published guidelines, despite their excellence, cannot keep up with evolving knowledge. Therefore, interactions with experts is needed. The following new developments, including but not limited to the following will be discussed:1)Asthma-COPD overlap syndrome, 2) sub-lingual immunotherapy (SLIT), 3) use of tiotropium (long-acting muscarinic antagonist), 4) Anti-IL5 treatment for adults with severe eosinophilic asthma, 5) Sputum eosinophilia level guided therapy, 6) bronchial thermoplasty, 7) remote monitoring of asthma.